title: European Study Group on Antibiotic Breakpoints. Breakpoint determination: sparfloxacin.
authors.forename: I
authors.initials: I
authors.lastname: Phillips
authors.forename: J
authors.initials: J
authors.lastname: Acar
authors.forename: F
authors.initials: F
authors.lastname: Baquero
authors.forename: T
authors.initials: T
authors.lastname: Bergan
authors.forename: J
authors.initials: J
authors.lastname: Degener
authors.forename: A
authors.initials: A
authors.lastname: Forsgren
authors.forename: G C
authors.initials: GC
authors.lastname: Schito
authors.forename: B
authors.initials: B
authors.lastname: Wiedemann
mesh_terms: D001424:Bacterial Infections / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D024841:Fluoroquinolones; D006801:Humans; D008826:Microbial Sensitivity Tests; D015363:Quinolones / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D024841:Fluoroquinolones; D015363:Quinolones; C061363:sparfloxacin